NCT07190677View on ClinicalTrials.gov

First-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

Non Small Cell Lung Cancer Metastatic

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER